Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 16,212

Document Document Title
WO/2023/222850A1
The specification relates to compounds of Formula (I): and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, to pharmaceutical compositions containing them and to their use in the tr...  
WO/2023/218933A1
The present invention addresses the problem of providing a photoelectric conversion element which has excellent quantum efficiency when receiving blue light, an imaging element, a photosensor, and a compound. This photoelectric conversio...  
WO/2023/215279A1
The invention relates to the unexpected discovery that the oral administration of charged sodium channel blockers, also called "Nocions," alleviates inflammation in intestinal inflammatory diseases, such as inflammatory bowel disease (IB...  
WO/2023/214935A1
The present disclosure provides improved processes for the preparation of Relugolix and intermediates thereof. Relugolix is prepared via intermediates (M7) and (M8):, wherein X is as described herein. Present disclosure also provides thr...  
WO/2023/210772A1
A first problem to be addressed by the present invention is to provide a photoelectric conversion element that has excellent quantum efficiency when receiving blue light. A second problem to be addressed by the present invention is to pr...  
WO/2023/211940A1
The present disclosure provides STING agonists, and compositions, formulations. and methods for treating diseases or disorders (e.g., cancer, inflammatory diseases, autoimmune diseases, and infectious diseases) with the STING agonists or...  
WO/2023/211930A1
The present disclosure provides dual functioning compounds, compositions, formulations, and methods for inducing or modulating an immune or inflammatory response and treating diseases or disorders (e.g., cancer, autoimmune diseases, infl...  
WO/2023/206835A1
The present invention belongs to the technical field of catalyst preparation, and discloses a cross-linked norbornene copolymer/carbon black three-dimensional network immobilized bimetallic copper/gold nano-catalyst, and a preparation me...  
WO/2023/202377A1
The present application provides a deuterated composition, an organic electroluminescent device, and a display apparatus. The deuterated composition comprises a deuterated mixture prepared from compound A by means of a deuteration reacti...  
WO/2023/202582A1
A compound of a GPR132 regulator, a pharmaceutically acceptable salt or ester, a prodrug, a stereoisomer, a hydrate, a solvate, a crystal form, or a metabolite form thereof, as well as a preparation method therefor and medicinal use ther...  
WO/2023/202198A1
The present application relates to an organic material, an electronic element, and an electronic apparatus. The organic material provided by the present application has a structure as shown in formula 1. The organic material is applied t...  
WO/2023/202578A1
The present invention relates to a GPCR regulator and use thereof, and particularly provides a compound represented by formula (I), or a stereoisomer, a prodrug, a crystal form, a pharmaceutically acceptable salt, a pharmaceutically acce...  
WO/2023/200196A1
The present invention relates to an organic compound employed in an organic layer in an organic light-emitting device, such as a hole transport layer and an electron blocking layer. The organic compound according to the present invention...  
WO/2023/200195A1
The present invention relates to an organic compound, which is employed for an organic layer, such as a hole transport layer or an electron block layer, of an organic light emitting diode. The organic compound according to the present in...  
WO/2023/200226A1
The present specification provides a compound represented by chemical formula 1 and an organic light-emitting device including the compound.  
WO/2023/200225A1
The present specification provides a compound represented by chemical formula 1 and an organic light-emitting device comprising same.  
WO/2023/199851A1
Provided are: a semiconductor substrate manufacturing method using a resist underlayer film-forming composition from which it is possible to form a film having excellent etching resistance, heat resistance, and bending resistance; a comp...  
WO/2023/195791A1
The present invention relates to a phenylpropenone backbone compound, which is a novel chromanone or a ring-opened form thereof, and a composition for preventing or treating multiple myeloma comprising same as an active ingredient. The c...  
WO/2023/193101A1
Antibacterial and or adjuvant compounds or pharmaceutically acceptable salts thereof according to Formula (I) are provided. Formula (I) in which R1-6 have the meanings described herein. Other methods of use are also provided.  
WO/2023/190987A1
Provided are: a compound represented by either formula (1) or formula (2) (where the symbols in formula (1) and formula (2) are as defined in the description); an organic electroluminescent element containing the compound; and an electro...  
WO/2023/171670A1
This resist composition, which generates an acid by being exposed to light and of which the solubility in a developer changes due to the action of the acid, contains a resin component (A1) of which the solubility in a developer changes d...  
WO/2023/171788A1
The present invention addresses the problem of providing: a photoelectric conversion element which is excellent in production applicability and also excellent in photoelectric conversion efficiency; an imaging element; a photosensor; and...  
WO/2023/169456A1
This disclosure relates to GLP-1 agonists, pharmaceutical compositions, and methods of use thereof.  
WO/2023/172818A1
The present disclosure provides polymorphs of 3-(2,3,5,6-tetrafluoro-3'-trifluoromethoxy-biphenyl-4-ylcarb amoyl)-thiophene-2-carboxylic acid, and methods of making such polymorphs. The present disclosure further provides pharmaceutical ...  
WO/2023/166203A1
The present invention relates to GPR120 agonists for use in the treatment of inflammatory bowel disease, in particular ulcerative colitis or Crohn's disease.  
WO/2023/160121A1
The present application belongs to the technical field of organic materials. Provided are an organic compound, an electronic element comprising same, and an electronic device, wherein the organic compound has a structure as represented b...  
WO/2023/162907A1
This resist composition includes a base component (A) and a compound (B0) represented by general formula (b0). In the formula, Ar0 is an arylene group or a hetero arylene group. Rm1 and Rm2 are substituents other than an iodine atom. L01...  
WO/2023/159303A1
Provided herein are Myc-Max inhibitory compounds having the structure of Formula I or Formula II and compositions thereof for use in the treatment of cancer. In particular, the Myc- Max inhibitory compounds may be useful for the treatmen...  
WO/2023/157862A1
Provided is a method for producing α-fluoroether starting from an inactivated chloride. Disclosed is a method for producing a compound represented by formula (3), the method comprising step A in which a compound represented by formula (...  
WO/2023/158795A1
Provided are compounds of the Formula (I): or pharmaceutically acceptable salts thereof, which are useful for the inhibition of DHX9 and in the treatment of a variety of DHX9 mediated conditions or diseases, such as cancer.  
WO/2023/151662A1
Provided are an androgen receptor activity regulator and the use thereof. The androgen receptor activity regulator has a structure as represented by formula 1-I or formula 2-I, wherein R1-R7, X, ring A, ring B, ring C, n, m, p, Z1 and Z2...  
WO/2023/152415A1
The present invention relates to a compound of formula I, wherein the groups R1 to R5 and Cy have the meaning described in the description, for use thereof in the treatment and/or prevention of an infection or disease caused by the infec...  
WO/2023/154519A1
Provided are compounds of the Formula (I); or pharmaceutically acceptable salts thereof, which are useful for the inhibition of DHX9 and in the treatment of a variety of DHX9 mediated conditions or diseases, such as cancer.  
WO/2023/153169A1
The present disclosure provides an organic compound represented by general formula (1). (In general formula (1), R1 to R20 are each independently selected from the group consisting of a hydrogen atom, a deuterium atom, a halogen atom, an...  
WO/2023/151394A1
The present invention relates to the technical field of organic electroluminescent materials, and in particular, to a fluorene derivative and a use thereof. The structural formula of the fluorene derivative is shown in formula (I). The f...  
WO/2023/147344A1
The present disclosure provides compounds of the formula: wherein the variables are defined herein, as well as pharmaceutical compositions thereof. The present disclosure also provides methods of inhibiting isocitrate dehydrogenase 1 (ID...  
WO/2023/146816A1
The present disclosure provides novel 4-substituted-phenyl acetamide and arylurea derivatives that act as agonists against GPR88. The compounds of the present disclosure are believed to be useful for the treatment of diseases and conditi...  
WO/2023/146343A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2023/146344A1
The present invention provides a novel compound and an organic light-emitting device comprising same.  
WO/2023/145535A1
This resist composition contains a resin component having a structural unit derived from a compound represented by general formula (a0-1) or a structural unit derived from a compound represented by general formula (a0-2). In the formulae...  
WO/2023/140173A1
Provided is a material for photoelectric conversion elements for imaging which renders increases in sensitivity and resolution possible. The material for photoelectric conversion elements for imaging comprises a thiophene derivative repr...  
WO/2023/134598A1
The present invention relates to a polymerisable compound, a composition, and a liquid crystal display device. The polymerisable compound of the present invention has the structure shown in general formula I. When the polymerisable compo...  
WO/2023/131667A1
Embodiments of the invention are directed to cooling compounds and cooling compositions having a unique cooling perception, as well as various edible, potable, and/or cosmetic products containing one or more cooling compounds having a ge...  
WO/2023/133240A1
Compositions and formulations for skin treatment are provided herein. Methods for skin treatment, such as methods for preventing or treating skin conditions, disorder, or disease are also provided herein. The methods may increase skin co...  
WO/2023/133336A1
Provided are compounds of Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating a variety of conditions associated with STAT3 and/or STAT6.  
WO/2023/132488A1
The present specification relates to a compound of chemical formula 1, and an organic light-emitting device comprising same.  
WO/2023/131951A1
Novel non-coded amino acids derivatives having herbicidal activity, agricultural compositions, process for their manufacture and their use in crop protection are provided.  
WO/2023/132895A1
A catalyst is provided that can provide improved results when producing thiophene by conversion of n-butane (and/or other alkanes) and a gas phase sulfur-containing compound, such as CS2, H2S, S2, or another form of sulfur. The catalyst ...  
WO/2023/126979A1
The present specification relates to pharmaceutical composition comprising duloxetine, or pharmaceutically acceptable salts thereof, and capsaicin. The present specification more particulary relates to topical pharmaceutical composition ...  
WO/2023/127807A1
In the production of agricultural and horticultural crops, etc., damages caused by pest insects, etc. are still significant, and, therefore, the development of novel pest control agents has been required due to factors such as the emerge...  

Matches 101 - 150 out of 16,212